BR112016001182A2 - Vetores de seleção e métodos de seleção de células hospedeiras eucarióticas - Google Patents
Vetores de seleção e métodos de seleção de células hospedeiras eucarióticasInfo
- Publication number
- BR112016001182A2 BR112016001182A2 BR112016001182A BR112016001182A BR112016001182A2 BR 112016001182 A2 BR112016001182 A2 BR 112016001182A2 BR 112016001182 A BR112016001182 A BR 112016001182A BR 112016001182 A BR112016001182 A BR 112016001182A BR 112016001182 A2 BR112016001182 A2 BR 112016001182A2
- Authority
- BR
- Brazil
- Prior art keywords
- selection
- methods
- host cells
- polypeptide
- vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/40—Systems of functionally co-operating vectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
VETOR DE EXPRESSÃO, CÉLULA HOSPEDEIRA E MÉTODOS PARA SUA PRODUÇÃO E SELEÇÃO, PROCESSO PARA PRODUZIR UM POLIPEPTÍDEO E SEU USO. A invenção se refere a um vetor de expressão ou uma combinação de ao menos dois vetores de expressão que compreendem: (a) um polinucleotídeo que codifica um receptor de folato mutado como marcador selecionável, em que o receptor de folato mutado tem uma menor afinidade de ligação ao folato se comparado com o receptor de folato do tipo selvagem; (b) pelo menos um polinucleotídeo que codifica um polipeptídeo de interesse, sendo que quando o dito vetor de expressão ou uma combinação de ao menos dois vetores de expressão são introduzidos em uma célula hospedeira, o polipeptídeo de interesse é secretado pela dita célula hospedeira. Também são fornecidas células hospedeiras adequadas, métodos de seleção e métodos para a produção de polipeptídeos com alto rendimento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361860439P | 2013-07-31 | 2013-07-31 | |
| PCT/IB2014/063517 WO2015015419A1 (en) | 2013-07-31 | 2014-07-29 | Novel selection vectors and methods of selecting eukaryotic host cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016001182A2 true BR112016001182A2 (pt) | 2017-08-29 |
Family
ID=51383909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016001182A BR112016001182A2 (pt) | 2013-07-31 | 2014-07-29 | Vetores de seleção e métodos de seleção de células hospedeiras eucarióticas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US11807855B2 (pt) |
| EP (3) | EP4095153A1 (pt) |
| JP (1) | JP6576924B2 (pt) |
| KR (1) | KR102288233B1 (pt) |
| CN (2) | CN112029791A (pt) |
| AU (1) | AU2014297966B2 (pt) |
| BR (1) | BR112016001182A2 (pt) |
| CA (1) | CA2918117C (pt) |
| DK (2) | DK3027646T3 (pt) |
| ES (2) | ES2920510T3 (pt) |
| HU (1) | HUE058885T2 (pt) |
| IL (1) | IL243352B (pt) |
| LT (2) | LT3412684T (pt) |
| MX (1) | MX369109B (pt) |
| PL (2) | PL3412684T3 (pt) |
| PT (2) | PT3027646T (pt) |
| RU (1) | RU2716977C2 (pt) |
| SG (1) | SG11201510625TA (pt) |
| WO (1) | WO2015015419A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2401377B1 (en) | 2009-02-27 | 2016-05-18 | Novartis AG | Expression vector system comprising two selection markers |
| AU2014297966B2 (en) | 2013-07-31 | 2017-10-26 | Novartis Ag | Novel selection vectors and methods of selecting eukaryotic host cells |
| EP3521435A1 (en) | 2018-02-06 | 2019-08-07 | Bayer AG | A high stringency selection system for protein expression in proline-auxotrophic cells |
| EP3847271A4 (en) * | 2018-09-07 | 2022-10-12 | MedImmune, LLC | CELL SELECTION METHODS |
| US20220348632A1 (en) | 2019-09-18 | 2022-11-03 | Novartis Ag | Nkg2d fusion proteins and uses thereof |
| JP2023550459A (ja) | 2020-11-23 | 2023-12-01 | ノバルティス アーゲー | 抗体構築物の発現技術 |
| JP2024517711A (ja) | 2021-04-29 | 2024-04-23 | ノバルティス アーゲー | 高シアル酸付加細胞 |
| WO2023122567A1 (en) * | 2021-12-21 | 2023-06-29 | Absci Corporation | Fola selection assay to identify strains with increased soluble target protein expression |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4771036A (en) | 1986-02-10 | 1988-09-13 | Trustees Of Columbia University In The City Of New York | Method and ophthalmic composition for the prevention and reversal of cataracts |
| JP2585532B2 (ja) | 1986-05-10 | 1997-02-26 | 三井東圧化学株式会社 | 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてｔ−ＰＡを生産する方法 |
| JP3150340B2 (ja) | 1990-11-13 | 2001-03-26 | イムネクス コーポレイション | 二機能選択可能融合遺伝子 |
| AU660671B2 (en) | 1991-03-29 | 1995-07-06 | Genentech Inc. | Methods for selection of recombinant host cells expressing high levels of a desired protein |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5439808A (en) | 1993-07-23 | 1995-08-08 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| US5830698A (en) | 1997-03-14 | 1998-11-03 | Idec Pharmaceuticals Corporation | Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| US6106825A (en) | 1997-05-07 | 2000-08-22 | University Of Florida | Entomopoxvirus-vertebrate gene delivery vector and method |
| FR2784030B1 (fr) | 1998-10-02 | 2002-12-20 | Inst Nat Sante Rech Med | Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine |
| FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
| US7384744B2 (en) | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| DE10256083A1 (de) | 2002-11-29 | 2004-08-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen |
| EA010096B1 (ru) | 2003-03-11 | 2008-06-30 | Лаборатуар Сероно Са | Экспрессирующие векторы, содержащие ie2-промотор mcmv |
| EP1716233B1 (en) | 2004-01-30 | 2009-08-26 | Maxygen Holdings Ltd. | Regulated stop codon readthrough |
| US20060275794A1 (en) | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
| CN101389763B (zh) | 2006-02-21 | 2013-01-23 | 科罗迈吉尼科斯公司 | 高水平表达蛋白质的宿主细胞的选择 |
| AU2007251766B2 (en) | 2006-05-17 | 2013-06-20 | F. Hoffmann-La Roche Ag | Polypeptide producing cells |
| BRPI0821311B1 (pt) | 2007-12-21 | 2018-09-18 | Novartis Ag | Ácido nucleico de vetor linearizado, método para produção de uma célula hospedeira de mamífero compreendendo o referido ácido, e método para produção de um polipetídeode interesse |
| CN103805633B (zh) | 2007-12-21 | 2016-09-07 | 诺华股份有限公司 | 有机化合物 |
| CA2734340C (en) | 2008-08-28 | 2019-03-05 | Novartis Ag | Cell surface display of polypeptide isoforms by stop codon readthrough |
| ES2548980T3 (es) | 2008-09-10 | 2015-10-22 | Inserm - Institut National De La Santé Et De La Recherche Médicale | Factor de viabilidad neuronal y uso del mismo |
| EP2401377B1 (en) | 2009-02-27 | 2016-05-18 | Novartis AG | Expression vector system comprising two selection markers |
| CN102333875B (zh) | 2009-02-27 | 2014-04-16 | 诺华股份有限公司 | 选择表达异源蛋白质的真核细胞的方法 |
| CN102030754B (zh) * | 2009-09-28 | 2013-07-10 | 中国科学院微生物研究所 | 非病毒载体及其制备方法与应用 |
| AU2014297966B2 (en) | 2013-07-31 | 2017-10-26 | Novartis Ag | Novel selection vectors and methods of selecting eukaryotic host cells |
-
2014
- 2014-07-29 AU AU2014297966A patent/AU2014297966B2/en active Active
- 2014-07-29 PT PT14753158T patent/PT3027646T/pt unknown
- 2014-07-29 HU HUE18179678A patent/HUE058885T2/hu unknown
- 2014-07-29 ES ES18179678T patent/ES2920510T3/es active Active
- 2014-07-29 WO PCT/IB2014/063517 patent/WO2015015419A1/en active Application Filing
- 2014-07-29 EP EP22166577.1A patent/EP4095153A1/en not_active Withdrawn
- 2014-07-29 EP EP14753158.6A patent/EP3027646B1/en active Active
- 2014-07-29 ES ES14753158.6T patent/ES2689136T3/es active Active
- 2014-07-29 BR BR112016001182A patent/BR112016001182A2/pt not_active Application Discontinuation
- 2014-07-29 PT PT181796780T patent/PT3412684T/pt unknown
- 2014-07-29 EP EP18179678.0A patent/EP3412684B1/en active Active
- 2014-07-29 PL PL18179678.0T patent/PL3412684T3/pl unknown
- 2014-07-29 CN CN202010947233.8A patent/CN112029791A/zh active Pending
- 2014-07-29 KR KR1020167002307A patent/KR102288233B1/ko active IP Right Grant
- 2014-07-29 US US14/907,866 patent/US11807855B2/en active Active
- 2014-07-29 MX MX2016001396A patent/MX369109B/es active IP Right Grant
- 2014-07-29 SG SG11201510625TA patent/SG11201510625TA/en unknown
- 2014-07-29 DK DK14753158.6T patent/DK3027646T3/en active
- 2014-07-29 DK DK18179678.0T patent/DK3412684T3/da active
- 2014-07-29 LT LTEP18179678.0T patent/LT3412684T/lt unknown
- 2014-07-29 CA CA2918117A patent/CA2918117C/en active Active
- 2014-07-29 LT LTEP14753158.6T patent/LT3027646T/lt unknown
- 2014-07-29 RU RU2016106270A patent/RU2716977C2/ru active
- 2014-07-29 CN CN201480054263.9A patent/CN105593239B/zh active Active
- 2014-07-29 PL PL14753158T patent/PL3027646T3/pl unknown
- 2014-07-29 JP JP2016530647A patent/JP6576924B2/ja active Active
-
2015
- 2015-12-24 IL IL243352A patent/IL243352B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112016001182A2 (pt) | Vetores de seleção e métodos de seleção de células hospedeiras eucarióticas | |
| PH12015501672A1 (en) | Binding molecules for bcma and cd3 | |
| MX2023011785A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
| MX2019008346A (es) | Receptores de celulas t que se unen a ny-eso-1 y metodos de uso de estos. | |
| CO2017005842A2 (es) | Anticuerpos heterodiméricos que se unen a cd3 y cd38 | |
| MX2019000643A (es) | Receptores de antigenos quimericos y metodos de uso. | |
| EP4273238A3 (en) | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity | |
| MX2017014125A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| BR112018074325A2 (pt) | anticorpo para ligação a receptor de interleucina 4 | |
| IN2014CN04586A (pt) | ||
| EP3741849A3 (en) | Protease variants and polynucleotides encoding same | |
| WO2015195769A3 (en) | Optogenetic probes for measuring membrane potential | |
| AR090158A1 (es) | Polipeptidos de union a cx3cr1 | |
| BR112016013443A2 (pt) | células eucarióticas e métodos para expressar recombinantemente um produto de interesse | |
| MX363261B (es) | Polipéptidos que tienen actividad de la fosfolipasa a y polinucleótidos que los codifican. | |
| BR112017004495A2 (pt) | variantes de celobiohidrolase e polinucleotídeos codificando as mesmas | |
| BR112017004233A2 (pt) | polipeptídeos tendo atividade de xilanase com uma alta taxa de conversão de polissacarídeos contendo xilose | |
| MX363360B (es) | Polipéptidos que poseen actividad proteasa y polinucleótidos que los codifican. | |
| MX2017005295A (es) | Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas. | |
| BR112018005464A2 (pt) | expressão de proteínas contendo fc | |
| ES2523016A1 (es) | Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes | |
| MX2016001678A (es) | Construcciones de expresion y metodos para expresar polipeptidos en celulas eucariotas. | |
| WO2014197069A3 (en) | Radiotracer imaging using sodium iodide symporter polypeptides | |
| Jiaqi et al. | Influence of water-saturated state on mechanical properties and longitudinal wave velocity of karst limestone | |
| Xiang-yu et al. | Reason and Precaution of Seepage in NATM Tunnel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |